Education
About Us
Working with TipRanks
Follow Us
MedCap AB (SE:MCAP)
:MCAP
Total Valuation
MedCap AB has a market cap or net worth of kr9.82B. The enterprise value is kr6.74B.
Market Capkr9.82B
Enterprise Valuekr6.74B
Share Statistics
MedCap AB has 15,044,353 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,044,353
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MedCap AB’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 12.66%.
Return on Equity (ROE)0.16
Return on Assets (ROA)0.10
Return on Invested Capital (ROIC)12.66%
Return on Capital Employed (ROCE)0.16
Revenue Per Employee3.17M
Profits Per Employee477.72K
Employee Count570
Asset Turnover0.91
Inventory Turnover2.79
Valuation Ratios
The current PE Ratio of MedCap AB is 49.0. MedCap AB’s PEG ratio is 2.12.
PE Ratio49.0
PS Ratio4.93
PB Ratio6.95
Price to Fair Value6.95
Price to FCF30.31
Price to Operating Cash Flow30.85
PEG Ratio2.12
Income Statement
In the last 12 months, MedCap AB had revenue of 1.81B and earned 207.40M in profits. Earnings per share was 13.99.
Revenue1.81B
Gross Profit1.06B
Operating Income272.30M
Pretax Income261.60M
Net Income207.40M
EBITDA396.00M
Earnings Per Share (EPS)13.99
Cash Flow
In the last 12 months, operating cash flow was 326.00M and capital expenditures -58.70M, giving a free cash flow of 267.30M billion.
Operating Cash Flow326.00M
Free Cash Flow267.30M
Free Cash Flow per Share17.77
Dividends & Yields
MedCap AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.51
52-Week Price Change26.06%
50-Day Moving Average535.85
200-Day Moving Average479.74
Relative Strength Index (RSI)64.91
Average Volume (3m)29.67K
Important Dates
MedCap AB upcoming earnings date is Oct 24, 2025, TBA (Confirmed).
Last Earnings DateJul 23, 2025
Next Earnings DateOct 24, 2025
Ex-Dividend Date―
Financial Position
MedCap AB as a current ratio of 2.77, with Debt / Equity ratio of 24.71%
Current Ratio2.77
Quick Ratio1.96
Debt to Market Cap<0.01
Net Debt to EBITDA-0.03
Interest Coverage Ratio14.33
Taxes
In the past 12 months, MedCap AB has paid 52.40M in taxes.
Income Tax52.40M
Effective Tax Rate0.20
Enterprise Valuation
MedCap AB EV to EBITDA ratio is 22.46, with an EV/FCF ratio of 30.27.
EV to Sales4.92
EV to EBITDA22.46
EV to Free Cash Flow30.27
EV to Operating Cash Flow24.70
Balance Sheet
MedCap AB has kr335.10M in cash and marketable securities with kr335.10M in debt, giving a net cash position of kr0.00 billion.
Cash & Marketable Securitieskr335.10M
Total Debtkr335.10M
Net Cashkr0.00
Net Cash Per Sharekr0.00
Tangible Book Value Per Sharekr41.92
Margins
Gross margin is 58.16%, with operating margin of 15.07%, and net profit margin of 11.48%.
Gross Margin58.16%
Operating Margin15.07%
Pretax Margin14.48%
Net Profit Margin11.48%
EBITDA Margin21.92%
EBIT Margin15.53%
Analyst Forecast
The average price target for MedCap AB is kr671.05, which is 11.43% higher than the current price. The consensus rating is Hold
Price Targetkr671.05
Price Target Upside1.06% Upside
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast9.32%
EPS Growth Forecast-7.55%